Homeβ€ΊSearchβ€ΊAtherosclerosis Plus

Atherosclerosis Plus

Elsevier Ireland Ltd Β· Ireland Β· Est. 2017

ISSN2667-0895
SJR Q2βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
11
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.723
H-Indexi
15
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.672
Total Worksi
274
Total Citationsi
833
2yr Mean Citednessi
1.40
Open Impact Factor alternative

Aims & Scope

Subject areas: Peripheral Vascular Diseases; Cardiology and Cardiovascular Medicine; Internal Medicine.

General Information

Country / RegionIreland
Primary LanguageEnglish
1st Year Published2017
Annual Volume~ 51 articles / year
StatusActive (last: 2026)
Total Publications274
Publisher OrgElsevier BV
OA Since2020
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~11 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC-ND, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
PorticoKoninklijke BibliotheekPMCCLOCKSS

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
Elsevier Ireland Ltd
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2667-0895
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
Portico, Koninklijke Bibliotheek, PMC, CLOCKSS
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
1
0
2017
46
248
2021
56
216
2022
44
230
2023
54
181
2024
55
40
2025
32
5
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ2
Internal MedicineQ2

Subject Classification

Web of Science Categories

Peripheral Vascular Diseases

Scopus Categories

Cardiology and Cardiovascular MedicineInternal Medicine

Research Topics (OpenAlex)

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsAtherosclerosis and Cardiovascular DiseasesCancer, Lipids, and MetabolismDiverse Scientific and Economic StudiesCholesterol and Lipid MetabolismLipid metabolism and disordersHuman auditory perception and evaluationEducational Robotics and EngineeringAdipokines, Inflammation, and Metabolic Diseases

Frequently asked questions about Atherosclerosis Plus

Is Atherosclerosis Plus a predatory journal?

PubScope has no integrity flags on record for Atherosclerosis Plus: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Atherosclerosis Plus?

Atherosclerosis Plus is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.40.

Is Atherosclerosis Plus indexed in Scopus and Web of Science?

Atherosclerosis Plus is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Atherosclerosis Plus?

Subject areas: Peripheral Vascular Diseases; Cardiology and Cardiovascular Medicine; Internal Medicine.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref